DocMorris AG (SWX:DOCM)
Switzerland · Delayed Price · Currency is CHF 7.33
-0.15 (-1.94%)
Jun 4, 2026, 5:30 PM CET
DocMorris AG Market Cap
DocMorris AG has a market cap or net worth of 359.89 million as of June 4, 2026. Its market cap has increased by 229.08% in one year.
Market Cap
359.89M
Enterprise Value
489.05M
Revenue
1.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
7.33
Market Cap Chart
Since July 6, 2017, DocMorris AG's market cap has decreased from 951.62M to 359.89M, a decrease of -62.18%. That is a compound annual growth rate of -10.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 359.89M | 24.46% |
| Dec 30, 2025 | 289.17M | 12.22% |
| Dec 30, 2024 | 257.68M | -70.05% |
| Dec 29, 2023 | 860.25M | 168.32% |
| Dec 30, 2022 | 320.60M | -86.71% |
| Dec 30, 2021 | 2.41B | -10.94% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 247.05B |
| Novartis AG | 206.85B |
| Galderma Group AG | 38.56B |
| Lonza Group AG | 34.67B |
| Kuros Biosciences AG | 756.08M |
| Basilea Pharmaceutica AG | 614.83M |
| COLTENE Holding AG | 298.77M |
| IVF Hartmann Holding AG | 292.91M |